BioLargo, Inc.
BLGO
$0.219
-$0.0027-1.22%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.19M | -1.16M | -1.01M | -537.00K | -441.00K |
| Total Depreciation and Amortization | 81.00K | 85.00K | 67.00K | 68.00K | 79.00K |
| Total Amortization of Deferred Charges | 39.00K | 28.00K | -- | -- | -- |
| Total Other Non-Cash Items | -16.00K | -65.00K | 217.00K | -200.00K | 203.00K |
| Change in Net Operating Assets | -1.03M | -723.00K | -1.19M | -951.00K | 8.00K |
| Cash from Operations | -2.12M | -1.83M | -1.92M | -1.62M | -151.00K |
| Capital Expenditure | -- | -- | 25.00K | -39.00K | -358.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 192.00K | -- | -82.00K | -- | -- |
| Cash from Investing | 192.00K | -- | -57.00K | -39.00K | -358.00K |
| Total Debt Issued | 721.00K | 590.00K | 864.00K | -- | -- |
| Total Debt Repaid | -5.00K | -4.00K | -2.00K | -4.00K | -3.00K |
| Issuance of Common Stock | 2.10M | 295.00K | -- | 768.00K | 1.00M |
| Repurchase of Common Stock | -- | -- | -1.28M | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 15.00K | -15.00K | 2.01M | -- | -- |
| Cash from Financing | 2.83M | 866.00K | 1.59M | 764.00K | 999.00K |
| Foreign Exchange rate Adjustments | 0.00 | -20.00K | 47.00K | 12.00K | -61.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 907.00K | -984.00K | -334.00K | -883.00K | 429.00K |